Evaxion Biotech A/S

NASDAQ: EVAX
Share price (12/20/24): $0.92
Market cap (12/20/24): $5.134 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Initial registration of new securities for foreign issuers – amended

Initial registration of new securities for foreign issuers – amended

Initial registration of new securities for foreign issuers

Prospectus supplement with pricing info

Initial registration of new securities for foreign issuers – amended

Ownership Filter

Armistice Capital, LLC

Merck & Company Inc.

Merck & Company Inc.

News Filter

Pursues Agreement With EIB to Bolster Equity Through Conversion of Debt Into Equity

Establishes New AI-derived Precision Cancer Vaccine Concept

Announces 2025 Milestones Reflecting Continued Strong Strategy Execution

To Present Preclinical Proof-Of-Concept for Precision ERV Cancer Vaccine Concept at ESMO Immuno-Oncology Congress

Receives and Appeals Delisting Determination From Nasdaq, Remains Committed to Nasdaq Listing

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness